Test Price
2,800 AED✅ Home Collection Available
MYF6 Gene Centronuclear Myopathy Type 3 Genetic Test in UAE | 2800 AED | DHA-Regulated
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily across all UAE Emirates).
- Clinical Guidance: Post-Test Telephonic Interpretation by DHA-Certified Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This genetic test examines the entire coding region of the MYF6 gene to identify pathogenic variants associated with Centronuclear Myopathy Type 3 (CNM3), a rare congenital neuromuscular disorder. Performed in our ISO-certified, DHA-regulated facility, the assay delivers definitive molecular results in 3–4 weeks, enabling precise clinical diagnosis, family planning, and tailored management.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Methodology | Full MYF6 gene sequencing by NGS (99.9% sensitivity) | Generic multi-gene panel, may lack dedicated MYF6 coverage |
| Turnaround Time | 3–4 Weeks (guaranteed) | Variable, often 4–6+ weeks |
| Clinical Support | Pre- & post-test genetic counselling by Consultant Medical Geneticist | Minimal interpretation, no integrated counselling |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) + DHA License 1143 | May lack ISO/DHA lab certification |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: “As a clinical geneticist, I emphasize that genetic testing for Centronuclear Myopathy Type 3 requires careful correlation with the patient’s clinical phenotype and family history. The NGS results from this assay are robust, but they must be interpreted within the broader medical context. Always continue your current treatment plan until your specialist integrates these findings. Follow-up consultations are essential for personalised management.”
Advisory Guidelines for Patients
Important: Do not discontinue, adjust, or delay any prescribed therapy based solely on genetic test results. Share your report with your treating physician for comprehensive evaluation. The test is not a substitute for regular medical care or emergency intervention.
Exclusion Criteria & Red Flags
- Exclusion criteria: Pregnant women (requires treating physician approval); minors under 18 years without legal guardian consent; acute febrile illness or active infection that may compromise DNA specimen.
- Red flags (seek emergency care immediately): Sudden severe muscle weakness, difficulty breathing or swallowing, chest pain, loss of consciousness. This test is not designed for acute diagnostic emergencies.
Patient FAQ & Clinical Guidance
1. What is the MYF6 gene test and why is NGS used?
The MYF6 gene NGS test detects mutations causing Centronuclear Myopathy Type 3 by sequencing the entire coding region to identify pathogenic variants with 99.9% accuracy. This method provides comprehensive analysis of the gene, enabling precise diagnosis and genetic counselling.
2. How long do results take and how will I receive them?
Results are delivered within 3 to 4 weeks via a secure DHA-compliant portal. The report includes a clinical interpretation from a consultant medical geneticist licensed by the Dubai Health Authority.
3. Is home blood collection available across all UAE Emirates?
Yes, our DHA-licensed VIP mobile phlebotomy team provides hospital-grade home collection for peripheral blood samples across Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain, daily from 8 AM to 11 PM, with temperature-controlled cold-chain transport.
UAE Regulatory & Data Privacy Adherence
Compliance with UAE Health Data Protection Frameworks
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All genetic data is handled under strict data governance, ensuring confidentiality and patient consent management.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Digital records and tele-counselling platforms comply with UAE’s health informatics standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Diagnostic procedures and clinical interpretations adhere to medical liability regulations, ensuring patient safety and informed consent.
Clinical & Logistical Metadata
| Test Name | MYF6 Gene Sequencing for Centronuclear Myopathy Type 3 (CNM3) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Sequencing |
| ICD-10-CM Code | G71.2 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians